$ARWR Headlines Despite skepticism, market technicals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ARWR Headlines

Despite skepticism, market technicals remain bullish 12:53 p.m. March 11, 2014 - Michael Ashbaugh
Despite skepticism, market technicals remain bullish 12:40 p.m. March 11, 2014 - Michael Ashbaugh
U.S. benchmarks rattle the cage on major resistance 1:16 p.m. Feb. 7, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:06 p.m. Jan. 28, 2014 - Michael Ashbaugh
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
A 6-pack of hedge fund moves to take note of 12:08 p.m. Oct. 21, 2013 - Insider Monkey
Six stocks poised to move higher 3:23 p.m. Oct. 2, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:00 p.m. Sept. 26, 2013 - The Trading Deck
Arrowhead reports positive data on hep B drug 2:10 p.m. Feb. 26, 2013 - MarketWatch.com
Six companies unveil share, unit offerings 8:45 a.m. Dec. 7, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:12 p.m. Aug. 13, 2012 - MarketWatch

Tiger Soup 9:22 a.m. April 29, 2014 - Seeking Alpha
First Week Of ARWR December 20th Options Trading 10:58 a.m. April 23, 2014 - TheStreet.com
Stock To Watch: Arrowhead Research Corporation (ARWR) In Perilous Reversal 9:52 a.m. April 17, 2014 - TheStreet.com
Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock 9:47 a.m. April 16, 2014 - TheStreet.com
Mid-Afternoon Market Update: Markets Trade in Highly Volatile Session as Talk of a Pull-Back is Widespread 2:59 p.m. April 15, 2014 - benzinga.com
Why Arrowhead Research (ARWR) Stock is Down Today 3:00 p.m. April 14, 2014 - TheStreet.com
Trade-Ideas: Arrowhead Research Corporation (ARWR) Is Today's "Dead Cat Bounce" Stock 10:15 a.m. April 7, 2014 - TheStreet.com
Stock To Watch: Arrowhead Research Corporation (ARWR) In Perilous Reversal 9:47 a.m. April 2, 2014 - TheStreet.com
Why Arrowhead Research (ARWR) Stock Is Up Today 11:24 a.m. April 1, 2014 - TheStreet.com
Interesting ARWR Put And Call Options For May 17th 11:52 a.m. March 26, 2014 - TheStreet.com
Trade of the Day: Teva Pharmaceuticals (TEVA) and Mylan (MYL) 5:04 a.m. March 26, 2014 - InvestorPlace.com
Deutsche Bank Remains Positive on Arrowhead Research Despite Weakness 7:03 a.m. March 25, 2014 - benzinga.com
Deutsche Bank Defends Arrowhead Amid ~16% Decline, Reiterates Buy 5:10 p.m. March 24, 2014 - benzinga.com
Hot Stocks for Tuesday, March 18 11:30 a.m. March 19, 2014 - WallStreetSectorSelector
Perilous Reversal Watch: Arrowhead Research Corporation (ARWR) 9:58 a.m. March 11, 2014 - TheStreet.com
3 Biotech Winners on Wednesday: Arrowhead, Osiris, Tekmira 2:49 p.m. March 5, 2014 - Wall St. Cheat Sheet
Why Arrowhead Research (ARWR) His a Five-Year High Today 2:31 p.m. March 5, 2014 - TheStreet.com
Today's Top Performers In Health Care 12:02 p.m. March 5, 2014 - TheStreet.com
Arrowhead Surges As Analysts Laud Hepatitis B Drug 10:14 a.m. March 5, 2014 - Investors Business Daily
Morning Movers for Mar. 5, 2014: FCEL, ARWR, SWHC, CPST Moving Higher 8:52 a.m. March 5, 2014 - benzinga.com


Arrowhead to Present at Deutsche Bank 39th Annual Health Care Conference 7:31 a.m. May 1, 2014 - BusinessWire - BZX
Arrowhead to Report Fiscal 2014 Second Quarter Financial Results 4:08 p.m. April 29, 2014 - BusinessWire - BZX
Top Gainers on the Move -- Research on Arrowhead Research, Endocyte, Ambac Financial, and ZIOPHARM Oncology 12:40 p.m. April 23, 2014 - PR Newswire - PRF
Patient Enrollment, Acquisitions, FDA Reviews, and Results of Earnings and Clinical Trials - Analyst Notes on Arrowhead, Providence, Durata, Orthofix, and Idera 8:00 a.m. April 4, 2014 - PR Newswire - PRF
Top Gainers under the Scanner -- Research on Trina Solar, JA Solar, Arrowhead Research, and King Digital Entertainment 9:59 a.m. April 2, 2014 - PR Newswire - PRF
Arrowhead Completes Enrollment of First Cohort in Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 7:30 a.m. April 1, 2014 - BusinessWire - BZX
Arrowhead Begins Dosing in Phase 2a Trial of RNAi Therapeutic ARC-520 in Chronic Hepatitis B Patients 7:30 a.m. March 24, 2014 - BusinessWire - BZX
Regulatory Approvals, Pricing of Public Offering, Stock Price Movements, and Financial Reports - Analyst Notes on Arrowhead, ANI, OraSure, Rigel, and Foundation Medicine 12:30 p.m. March 10, 2014 - PR Newswire - PRF
Arrowhead to Present at Barclays Global Healthcare Conference 7:30 a.m. March 10, 2014 - BusinessWire - BZX
Pre-Market Top Gainers Analysis: Smith & Wesson Holding, DryShips, Arrowhead Research and ZBB Energy 12:38 p.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Autodesk, Pfizer, Arrowhead Research, Discover Financial, and Vodafone Released By InvestorsObserver 9:31 a.m. March 6, 2014 - PR Newswire - PRF
Arrowhead Receives Regulatory Approval to Begin Phase 2a Trial of Chronic Hepatitis B Candidate ARC-520 7:30 a.m. March 3, 2014 - BusinessWire - BZX
Arrowhead Closes Underwritten Offering with Gross Proceeds of $120 Million 8:59 a.m. Feb. 24, 2014 - BusinessWire - BZX
Arrowhead Listing Upgraded to NASDAQ Global Select Market 7:30 a.m. Feb. 21, 2014 - BusinessWire - BZX
Arrowhead to Present at RBC Capital Markets' Global Healthcare Conference 4:01 p.m. Feb. 20, 2014 - BusinessWire - BZX
Judge Approves Lehman Brothers $767M Settlement; Arrowhead Research Hits New 52-week High 12:30 a.m. Feb. 20, 2014 - ACCESSWIRE
Arrowhead Announces Pricing of Underwritten Offering of Common Stock 9:05 a.m. Feb. 19, 2014 - BusinessWire - BZX
Arrowhead Announces Proposed Underwritten Offering of Common Stock 4:14 p.m. Feb. 18, 2014 - BusinessWire - BZX
Arrowhead Reports Fiscal 2014 First Quarter Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Arrowhead to Participate in Panel Discussions at 16th Annual BIO CEO & Investor Conference 7:30 a.m. Feb. 4, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 5

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 2

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 2

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading

Top 5 Most Recently Viewed Articles

RCI Banque Releases Pillar III Report for 2024

Updated Category News Views 211

RCI Banque: Highlights from the Pillar III Report for 2024 RCI Banque has released its Pillar III Report, which contains essential financial and risk management data as of June 30, 2024. This report plays a vital role in ensuring transparency about the bank's risk exposures and capital requirements. What is the Pillar III Report? The Pillar III Report is a crucial element...

Continue Reading
Popsmith Popper Recognized in Oprah’s 2024 Gift List

Updated Category News Views 401

Popsmith Celebrated in Oprah’s Favorite Things List for 2024 In an exciting announcement from Seattle, Popsmith is thrilled to reveal that its signature product, the Popsmith Popper, has been selected for the esteemed Oprah’s Favorite Things holiday gifts list for 2024. This recognition not only highlights the fantastic functionality of their popcorn maker, but also...

Continue Reading
Lyell Immunopharma Secures Major Funding for Innovative Therapies

Updated Category News Views 283

Lyell Immunopharma's Strategic Funding Announcement Lyell Immunopharma, Inc. (NASDAQ: LYEL), a pioneering clinical-stage company, recently declared an exciting advancement in their funding strategy with a private placement of equity aimed at generating up to $100 million. This initiative signifies a robust step forward in their mission to develop next-generation CAR...

Continue Reading
Caterpillar Transitions Leadership with New CEO and Executive Chairman

Updated Category News Views 313

Caterpillar's Leadership Transition: A New Era Begins Caterpillar Inc. recently announced a significant shift in its leadership, marking the end of an era for one of its most prominent figures. After nearing half a century with the company, D. James Umpleby III, the Chairman and CEO, will transition to the role of Executive Chairman of the Board. Meanwhile, Joseph E....

Continue Reading
Levi & Korsinsky Files Class Action for Red Cat Holdings (RCAT)

Updated Category News Views 152

Levi & Korsinsky Takes Action for Red Cat Holdings Investors Levi & Korsinsky, LLP, a prominent securities law firm, has stepped forward to notify investors of Red Cat Holdings, Inc. regarding a class action lawsuit. This action specifically targets individuals who invested in Red Cat Holdings, Inc. (RCAT) and may have suffered losses due to alleged fraudulent activities....

Continue Reading